FDA Grants Pemivibart Emergency Use Authorization for PrEP of COVID-19 in Immunocompromised Patients
The indication is for adults and adolescents with moderate to severe immune compromise due to medical conditions or immunosuppressive medications and treatments.
Cameronr Wolfe Dave Hering Deficiency Foundation Duke University School Of Medicine Invivyd Inc Adults With Immune Compromise
Source: pharmacytimes.com